Value currently underperforming
High conviction portfolio
Tech not immune from growth concerns
Two hard years for African equities
Biotech has fallen
Tom Delic, assistant fund manager at Seneca Investment Managers explores the demographic trends – from opportunities in tech to wealth management – that are available for investors to take advantage of
Just over a month ago, volatility, as measured by the VIX index was around 26%, the highest reading since the Chinese slowdown scare of last August. The FTSE 100 was plunging, reaching its nadir of 5,500 in the morning of 11 February.
Growth in derivative-based defined return investments
The biotechnology sector has been hit particularly hard by the risk-averse sentiment sweeping through global stock markets and after reaching a high in July 2015, the Nasdaq Biotechnology index shed about one-third of its value.
If you buy the 30-year inflation protected gilt today and hold it to maturity you are guaranteed to lose 24% of your real capital. Where should you put your money instead?
The FTSE ET 100 returned 5% versus the MSCI All Countries World index, which advanced 3.3%, in 2015 rounding off what was a successful year for environment markets.
Changing demographics in developed nations, a growing demand for both digital and physical infrastructure, and renewed interest in good corporate behaviour are set to rule 2016 and beyond.
2016 could turn out to be an interesting year for equities but investors will need patience, commitment and steady nerves in large doses, according to Charles L. Heenan, investment director at Kennox.
Investing in tech start-ups is one of the most exciting investment opportunity sets available at present. But the mesmerising potential investment rewards require a combination of many highly specialist skills, says Alexander Selegenev, executive director...
David Saunders, founding managing director of K2 Advisors, Franklin Templeton, explains how an allocation to hedged strategies can help investors outperform.
Recognise boutiques and passive investing
'Fear and greed' are two powerful drivers of stock markets, if the old Wall Street adage is to be believed. But how relevant is this saying in today's sophisticated financial world?
Focus on high quality companies
Active categories include healthcare and EM debt
Investors have stayed away from ethical funds as they supposedly have to give up returns in order to be ‘socially conscious'. Hardeep Tawakley reports
ESG factors can have positive impact on performance
After several years of bad news for the holders of open-ended but suspended life settlements funds, there is perhaps a glimmer of hope.
Encouraging bond issuance in the sector